STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models
Oncotarget - United States
doi 10.18632/oncotarget.25825
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 18, 2018
Authors
Publisher
Impact Journals, LLC